DNA Microarray Detection of 18 Important Human Blood Protozoan Species.

Mu-Xin Chen,Lin Ai,Jun-Hu Chen,Xinyu Feng,Shao-Hong Chen,Yan Lu,Xiao-Nong Zhou,Jia-Xu Chen,Wei Hu
DOI: https://doi.org/10.1371/journal.pntd.0005160
2016-01-01
PLoS Neglected Tropical Diseases
Abstract:Background Accurate detection of blood protozoa from clinical samples is important for diagnosis, treatment and control of related diseases. In this preliminary study, a novel DNA microarray system was assessed for the detection of Plasmodium, Leishmania, Trypanosoma, Toxoplasma gondii and Babesia in humans, animals, and vectors, in comparison with microscopy and PCR data. Developing a rapid, simple, and convenient detection method for protozoan detection is an urgent need. Methodology/Principal Findings The microarray assay simultaneously identified 18 species of common blood protozoa based on the differences in respective target genes. A total of 20 specific primer pairs and 107 microarray probes were selected according to conserved regions which were designed to identify 18 species in 5 blood protozoan genera. The positive detection rate of the microarray assay was 91.78% (402/438). Sensitivity and specificity for blood protozoan detection ranged from 82.4% (95%CI: 65.9% similar to 98.8%) to 100.0% and 95.1% (95%CI: 93.2% similar to 97.0%) to 100.0%, respectively. Positive predictive value (PPV) and negative predictive value (NPV) ranged from 20.0% (95%CI: 2.5% similar to 37.5%) to 100.0% and 96.8% (95%CI: 95.0% similar to 98.6%) to 100.0%, respectively. Youden index varied from 0.82 to 0.98. The detection limit of the DNA microarrays ranged from 200 to 500 copies/reaction, similar to PCR findings. The concordance rate between microarray data and DNA sequencing results was 100%. Conclusions/Significance Overall, the newly developed microarray platform provides a convenient, highly accurate, and reliable clinical assay for the determination of blood protozoan species.
What problem does this paper attempt to address?